These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone. Sperling IL Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850 [No Abstract] [Full Text] [Related]
9. Withdrawal of oxyphenbutazone: what about phenylbutazone? Biron P CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857 [No Abstract] [Full Text] [Related]
10. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
11. Fixed drug eruption to oxyphenbutazone and phenylbutazone. Nayyar KC; Pasricha JS Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722 [No Abstract] [Full Text] [Related]
12. Letter: Fixed skin eruption caused by oxyphenbutazone with cross-reactivity to phenylbutazone. Pandhi RK; Dedi TR Arch Dermatol; 1975 Jan; 111(1):131. PubMed ID: 1119818 [No Abstract] [Full Text] [Related]
13. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
14. Phenylbutazone and oxyphenbutazone: time to call a halt. Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755 [No Abstract] [Full Text] [Related]
15. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica. Wadman B; Werner I Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976 [No Abstract] [Full Text] [Related]
16. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
17. Contact sensitivity to bufexamac. Lachapelle JM Contact Dermatitis; 1975 Aug; 1(4):261. PubMed ID: 139242 [No Abstract] [Full Text] [Related]
18. [Severe contact dermatitis caused by bufexamac with large flap desquamation]. Landrieux C; Estève E; Serpier H; Kalis B Ann Dermatol Venereol; 1996; 123(3):198-9. PubMed ID: 8761786 [No Abstract] [Full Text] [Related]
19. [Severe contact dermatitis caused by Parfenac cream]. Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349 [TBL] [Abstract][Full Text] [Related]
20. Contact dermatitis due to bufexamac. Watanabe K; Yoshikawa K Contact Dermatitis; 1983 Sep; 9(5):433. PubMed ID: 6627935 [No Abstract] [Full Text] [Related] [Next] [New Search]